» Articles » PMID: 35766348

Alcohol Misuse in Patients with Alcohol-related Liver Disease: How Can We Do Better? A Narrative Review of the Literature

Overview
Specialty Psychiatry
Date 2022 Jun 29
PMID 35766348
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ongoing alcohol use is strongly associated with progressive liver damage and higher mortality in patients with alcohol-related liver disease (ArLD). Reduction in alcohol use is therefore the cornerstone of treatment to improve the long-term outcome of these patients. However, a large proportion of patients continue to use alcohol and do not access or engage with alcohol treatment services after a diagnosis of ArLD. We reviewed the literature on factors associated with ongoing alcohol consumption among patients with ArLD to identify barriers or facilitators to their accessing alcohol treatment.

Methods: A search of MEDLINE and EMBASE was conducted using search strategies relating to ArLD and the psychosocial factors hypothesized to influence alcohol reduction and/or abstinence.

Results: There were few relevant studies pertinent to this population group. Several studies reported a high prevalence of mental health diagnoses associated with the severity of alcohol dependence. Social and environmental factors were shown to be important determinants of alcohol use. Common themes perceived as barriers to treatment from qualitative interviews with ArLD patients across studies included poor communication between the clinical team and patient, lack of symptoms recognized by patients themselves, and perceived loss of control over their condition.

Conclusions: We recommend that future clinical studies of patient cohorts with ArLD include detailed psychosocial assessments to capture information on mental health and social factors. Qualitative studies are required to explore the patient journey pre and post hospital admission, which should focus on identifying facilitators and barriers to accessing treatment. Well-designed, controlled studies are needed to identify patient, social, and environmental factors associated with relapse to alcohol use after a diagnosis of ArLD. These data will enable us to adapt our support for patients to enhance engagement with services and improve long-term outcomes.

Citing Articles

A qualitative enquiry into participants' and practitioners' experiences in the Australian Liver FaIlurE trial.

Ramachandran J, Pati A, Wigg L, Narayana S, Lawn S, Muller K BMJ Open. 2025; 15(2):e089666.

PMID: 39956593 PMC: 11831275. DOI: 10.1136/bmjopen-2024-089666.


Effect of family intervention on relapse rate of Chinese patients with alcohol-dependent.

Wang Y, Tang S, Chen G, Xia J, Wang L, Zhang H Front Public Health. 2024; 12:1327844.

PMID: 38841657 PMC: 11150763. DOI: 10.3389/fpubh.2024.1327844.


Genetically predicted fatty liver disease and risk of psychiatric disorders: A mendelian randomization study.

Xu W, Zhang H, Feng Y, Li S, Xie B World J Clin Cases. 2024; 12(14):2359-2369.

PMID: 38765736 PMC: 11099412. DOI: 10.12998/wjcc.v12.i14.2359.


Multiplatform web app (My Way Up) plus motivational interviewing for improving treatment retention in patients with onset of alcohol-related liver disease and alcohol use disorder - an example of participatory research.

Caballeria E, Balcells-Olivero M, Bataller R, Bruguera P, Cabrera N, Estruch A Digit Health. 2024; 10:20552076241242787.

PMID: 38715972 PMC: 11075580. DOI: 10.1177/20552076241242787.


Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study.

Wu M, Qin S, Tan C, Li S, Xie O, Wan X BMC Med. 2023; 21(1):277.

PMID: 37501074 PMC: 10375628. DOI: 10.1186/s12916-023-02984-7.


References
1.
Mikkelsen M, Hendriksen C, Schiodt F, Rydahl-Hansen S . Alcoholic liver disease patients' perspective of a coping and physical activity-oriented rehabilitation intervention after hepatic encephalopathy. J Clin Nurs. 2016; 25(17-18):2457-67. DOI: 10.1111/jocn.13265. View

2.
Mellinger J, Winder G, DeJonckheere M, Fontana R, Volk M, Lok A . Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis. J Subst Abuse Treat. 2018; 91:20-27. DOI: 10.1016/j.jsat.2018.05.003. View

3.
Buzzetti E, Kalafateli M, Thorburn D, Davidson B, Thiele M, Gluud L . Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis. Cochrane Database Syst Rev. 2017; 3:CD011646. PMC: 6464309. DOI: 10.1002/14651858.CD011646.pub2. View

4.
Presky J, Webzell I, Murrells T, Heaton N, Lau-Walker M . Understanding alcohol-related liver disease patients' illness beliefs and views about their medicine. Br J Nurs. 2018; 27(13):730-736. DOI: 10.12968/bjon.2018.27.13.730. View

5.
McHugh R, Weiss R . Alcohol Use Disorder and Depressive Disorders. Alcohol Res. 2019; 40(1). PMC: 6799954. DOI: 10.35946/arcr.v40.1.01. View